Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Aug 2016 for INTERLEUKIN GENETICS INC, €9,022.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark B. Carbeau: trading record in brief
One trade, one date: on 1 August 2016, Mark B. Carbeau disclosed an open-market purchase of €9,022 in Interleukin Genetics Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark B. Carbeau
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
100,603 shares@ US$0.0994100.0% of flowCommon StockSEC:0001144204-16-115761:0
Canonical exit: 27 Oct 2016 (T+90)
1 of 1 declaration
